Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rajiv Malik
Pharma
Viatris, former president cleared in DOJ price-fixing probe
Mylan and its former president are no longer considered to be "subjects of interest" in a federal generic industry antitrust probe.
Eric Sagonowsky
Jul 2, 2024 9:40am
In its 'trough year' Viatris is exceeding expectations
Aug 10, 2021 6:58am
Mylan execs to net $71M-plus in payouts after Pfizer deal wraps
Oct 29, 2019 11:53am
Mylan draws scrutiny again, this time in Italy
May 11, 2018 11:33am
